Daniel Stephenson
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pre-Eclampsia | 2 | 2023 | 187 | 0.920 |
Why?
| Eicosanoids | 6 | 2023 | 55 | 0.730 |
Why?
| Premature Birth | 1 | 2023 | 304 | 0.690 |
Why?
| Group IV Phospholipases A2 | 5 | 2023 | 45 | 0.640 |
Why?
| Sphingolipids | 6 | 2024 | 63 | 0.600 |
Why?
| Lipids | 2 | 2020 | 614 | 0.500 |
Why?
| Biomarkers | 3 | 2023 | 3662 | 0.490 |
Why?
| Ceramides | 4 | 2022 | 105 | 0.470 |
Why?
| Metabolomics | 2 | 2024 | 550 | 0.470 |
Why?
| Aspirin | 2 | 2023 | 344 | 0.340 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 44 | 0.270 |
Why?
| Placenta | 2 | 2023 | 648 | 0.270 |
Why?
| Carrier Proteins | 2 | 2020 | 740 | 0.260 |
Why?
| Eye Injuries | 1 | 2024 | 46 | 0.230 |
Why?
| Fluoxetine | 1 | 2023 | 47 | 0.230 |
Why?
| Calcium | 2 | 2019 | 1244 | 0.230 |
Why?
| Hemolysis | 1 | 2024 | 167 | 0.220 |
Why?
| Mast Cells | 1 | 2023 | 121 | 0.220 |
Why?
| Blood Donors | 1 | 2024 | 109 | 0.220 |
Why?
| Mustard Gas | 1 | 2024 | 119 | 0.210 |
Why?
| Retinal Diseases | 1 | 2022 | 81 | 0.200 |
Why?
| Head Injuries, Closed | 1 | 2021 | 55 | 0.200 |
Why?
| Movement Disorders | 1 | 2021 | 45 | 0.200 |
Why?
| Affective Symptoms | 1 | 2021 | 52 | 0.200 |
Why?
| Wound Healing | 2 | 2022 | 279 | 0.200 |
Why?
| Tandem Mass Spectrometry | 1 | 2023 | 423 | 0.190 |
Why?
| Inflammation | 5 | 2024 | 2598 | 0.190 |
Why?
| Macrophages, Peritoneal | 1 | 2020 | 97 | 0.190 |
Why?
| Macular Degeneration | 1 | 2022 | 152 | 0.190 |
Why?
| Fatty Acids, Omega-3 | 1 | 2021 | 127 | 0.190 |
Why?
| Vision Disorders | 1 | 2021 | 134 | 0.180 |
Why?
| Cadherins | 1 | 2021 | 190 | 0.180 |
Why?
| Antirheumatic Agents | 1 | 2022 | 254 | 0.180 |
Why?
| Reperfusion Injury | 1 | 2021 | 279 | 0.170 |
Why?
| Phosphatidylcholines | 1 | 2019 | 136 | 0.170 |
Why?
| Cell Death | 1 | 2020 | 345 | 0.160 |
Why?
| Necrosis | 1 | 2018 | 238 | 0.160 |
Why?
| Mass Spectrometry | 2 | 2020 | 686 | 0.160 |
Why?
| Neutrophils | 1 | 2023 | 1246 | 0.150 |
Why?
| Lipid Metabolism | 1 | 2020 | 482 | 0.150 |
Why?
| Sepsis | 1 | 2023 | 546 | 0.150 |
Why?
| Mice | 9 | 2024 | 15888 | 0.150 |
Why?
| Colonic Neoplasms | 1 | 2018 | 230 | 0.140 |
Why?
| Disease | 1 | 2017 | 100 | 0.140 |
Why?
| Autophagy | 1 | 2020 | 321 | 0.140 |
Why?
| Brain Concussion | 1 | 2021 | 470 | 0.120 |
Why?
| Animals | 11 | 2024 | 34133 | 0.120 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 967 | 0.120 |
Why?
| Mice, Inbred C57BL | 5 | 2021 | 5020 | 0.120 |
Why?
| Acute Kidney Injury | 1 | 2021 | 755 | 0.120 |
Why?
| Pregnancy | 2 | 2023 | 5854 | 0.120 |
Why?
| Macrophages | 1 | 2019 | 1334 | 0.110 |
Why?
| Cross-Sectional Studies | 1 | 2023 | 4734 | 0.110 |
Why?
| Infant, Newborn | 1 | 2023 | 5430 | 0.100 |
Why?
| Lung Neoplasms | 1 | 2022 | 2216 | 0.090 |
Why?
| Humans | 9 | 2024 | 122796 | 0.080 |
Why?
| Recombinant Proteins | 2 | 2021 | 1318 | 0.070 |
Why?
| Signal Transduction | 1 | 2019 | 4902 | 0.070 |
Why?
| Cell Movement | 2 | 2022 | 929 | 0.070 |
Why?
| Mice, Transgenic | 2 | 2021 | 2079 | 0.070 |
Why?
| Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.060 |
Why?
| Eyelids | 1 | 2024 | 24 | 0.060 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3388 | 0.060 |
Why?
| Kynurenine | 1 | 2024 | 81 | 0.060 |
Why?
| Autocrine Communication | 1 | 2023 | 43 | 0.060 |
Why?
| Mechlorethamine | 1 | 2024 | 68 | 0.060 |
Why?
| Female | 4 | 2023 | 63629 | 0.060 |
Why?
| Mice, Knockout | 2 | 2019 | 2737 | 0.060 |
Why?
| Feedback | 1 | 2023 | 155 | 0.060 |
Why?
| Autophagosomes | 1 | 2022 | 21 | 0.050 |
Why?
| Rabbits | 1 | 2024 | 808 | 0.050 |
Why?
| Arachidonic Acids | 1 | 2022 | 57 | 0.050 |
Why?
| Hydroxychloroquine | 1 | 2022 | 58 | 0.050 |
Why?
| Immunoglobulin E | 1 | 2023 | 368 | 0.050 |
Why?
| Sphingomyelin Phosphodiesterase | 1 | 2021 | 26 | 0.050 |
Why?
| Cell Proliferation | 2 | 2019 | 2328 | 0.050 |
Why?
| Disease Resistance | 1 | 2021 | 29 | 0.050 |
Why?
| Lysosomes | 1 | 2022 | 136 | 0.050 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 243 | 0.050 |
Why?
| Adenosine Triphosphate | 1 | 2023 | 456 | 0.050 |
Why?
| Tomography, Optical Coherence | 1 | 2022 | 134 | 0.050 |
Why?
| Brain Chemistry | 1 | 2021 | 120 | 0.050 |
Why?
| Cisplatin | 1 | 2022 | 269 | 0.050 |
Why?
| Mammals | 1 | 2022 | 257 | 0.050 |
Why?
| Thrombin | 1 | 2021 | 140 | 0.050 |
Why?
| Naphthalenes | 1 | 2020 | 43 | 0.050 |
Why?
| Ketones | 1 | 2020 | 45 | 0.050 |
Why?
| Thromboxane B2 | 1 | 2019 | 28 | 0.050 |
Why?
| Blood Preservation | 1 | 2024 | 304 | 0.050 |
Why?
| Hydroxyeicosatetraenoic Acids | 1 | 2019 | 41 | 0.050 |
Why?
| Blood Coagulation | 1 | 2021 | 226 | 0.040 |
Why?
| Retina | 1 | 2022 | 277 | 0.040 |
Why?
| Tensile Strength | 1 | 2019 | 100 | 0.040 |
Why?
| Cations, Divalent | 1 | 2019 | 54 | 0.040 |
Why?
| Cytosol | 1 | 2019 | 229 | 0.040 |
Why?
| Dinoprostone | 1 | 2019 | 193 | 0.040 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 19 | 0.040 |
Why?
| Cytoplasm | 1 | 2019 | 276 | 0.040 |
Why?
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 32 | 0.040 |
Why?
| Cyclin-Dependent Kinase 2 | 1 | 2018 | 36 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 71 | 0.040 |
Why?
| Erythrocytes | 1 | 2024 | 636 | 0.040 |
Why?
| Fear | 1 | 2021 | 313 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2020 | 588 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 114 | 0.040 |
Why?
| Amino Acid Substitution | 1 | 2019 | 278 | 0.040 |
Why?
| Mutagenesis, Site-Directed | 1 | 2019 | 368 | 0.040 |
Why?
| DNA Mutational Analysis | 1 | 2019 | 390 | 0.040 |
Why?
| Microscopy, Fluorescence | 1 | 2019 | 418 | 0.040 |
Why?
| Fatty Acids | 1 | 2020 | 410 | 0.040 |
Why?
| Collagen | 1 | 2019 | 436 | 0.040 |
Why?
| Mitochondria | 1 | 2022 | 809 | 0.040 |
Why?
| Cell Nucleus | 1 | 2019 | 598 | 0.040 |
Why?
| Cell Cycle | 1 | 2018 | 584 | 0.030 |
Why?
| Cytokines | 1 | 2023 | 1928 | 0.030 |
Why?
| Up-Regulation | 1 | 2018 | 891 | 0.030 |
Why?
| Fibroblasts | 1 | 2019 | 846 | 0.030 |
Why?
| Skin | 1 | 2019 | 694 | 0.030 |
Why?
| Oxidative Stress | 1 | 2021 | 1204 | 0.030 |
Why?
| Genotype | 1 | 2019 | 1943 | 0.030 |
Why?
| Phosphorylation | 1 | 2018 | 1733 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2024 | 3799 | 0.030 |
Why?
| Kidney | 1 | 2021 | 1355 | 0.030 |
Why?
| Protein Binding | 1 | 2019 | 2010 | 0.030 |
Why?
| Depression | 1 | 2021 | 1190 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2018 | 2904 | 0.030 |
Why?
| Phenotype | 1 | 2019 | 3070 | 0.020 |
Why?
| Male | 3 | 2021 | 59639 | 0.020 |
Why?
| Apoptosis | 1 | 2018 | 2532 | 0.020 |
Why?
| Treatment Outcome | 1 | 2020 | 9692 | 0.020 |
Why?
| Adolescent | 1 | 2020 | 18948 | 0.010 |
Why?
| Child | 1 | 2020 | 19561 | 0.010 |
Why?
| Adult | 1 | 2020 | 32385 | 0.010 |
Why?
|
|
Stephenson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|